| Serial Number | 86418815 |
| Word Mark | TOLERO PHARMACEUTICALS |
| Filing Date | Wednesday, October 8, 2014 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, December 10, 2021 |
| Registration Number | 4751574 |
| Registration Date | Tuesday, June 9, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 24, 2015 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
| Goods and Services | Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of new technology for others in the field of pharmacology; Development of pharmaceutical preparations and medicines; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of pharmacology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of pharmacology; Medical and scientific research information in the field of pharmacology; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Working on and evaluation of chemical analyses; Working on and evaluation of chemical syntheses |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 10, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, August 1, 2011 |
| First Use In Commerce Date | Monday, August 1, 2011 |
| Party Name | SUMITOMO DAINIPPON PHARMA CO., LTD. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | OSAKA-SHI, OSAKA 541-0045 JP |
| Party Name | Tolero Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Lehi, UT 84043 |
| Party Name | Tolero Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lehi, UT 84043 |
| Party Name | Tolero Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lehi, UT 84043 |
| Event Date | Event Description |
| Friday, December 10, 2021 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, June 9, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, February 9, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, February 9, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, December 13, 2017 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, June 9, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 24, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 24, 2015 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 4, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, February 14, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, February 13, 2015 | ASSIGNED TO LIE |
| Tuesday, January 27, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 27, 2015 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, January 27, 2015 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 27, 2015 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 27, 2015 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, January 27, 2015 | ASSIGNED TO EXAMINER |
| Wednesday, October 15, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, October 11, 2014 | NEW APPLICATION ENTERED IN TRAM |